Long-Term Outcomes of Transsphenoidal Surgery for Pediatric Cushing's Disease: A Single-center Cohort With 313 Patient-years of Follow-up

For a child, growing taller is often the most visible sign of health, a steady march toward adulthood measured in inches and shoe sizes. But in a rare condition known as Cushing's disease, the body's internal growth engine is hijacked by too much of a hormone called cortisol. This hormone, normally released by the adrenal glands to help the body handle stress, becomes overproduced because of a tiny, benign tumor on the pituitary gland, a small structure at the base of the brain that acts as a master switch for many bodily functions. In children, this excess cortisol creates a cruel paradox: they gain weight rapidly, often developing a round face and a heavy torso, yet they stop growing taller. Their bones may weaken, their blood pressure can rise, and their mood and energy levels can swing wildly. While this condition is well-known in adults, it is exceptionally rare in children, making it difficult for doctors to gather enough information to know the best way to treat it over the long term.

A team of surgeons and endocrinologists at the All India Institute of Medical Sciences in New Delhi set out to fill this gap in knowledge. They looked back at the medical records of thirty-seven children, all under the age of eighteen, who had undergone a specific type of brain surgery to remove the tumor causing their disease. This surgery, called transsphenoidal surgery, involves reaching the pituitary gland through the nose, avoiding the need to open the skull. The researchers followed these patients for an exceptionally long time, accumulating a total of 313 patient-years of observation across the entire group. Their goal was to see not just if the surgery worked immediately, but whether the children stayed healthy years later, if their bodies recovered from the damage caused by the disease, and what happened if the tumor came back.

The children in this group were mostly teenagers, with a median age of fourteen at the time of diagnosis. Like many others with this condition, their most common complaint was rapid weight gain, which affected nearly nine out of ten of them. Many also suffered from high blood pressure, darkening of the skin, and the sudden appearance of stretch marks. Before the surgery, the doctors used magnetic resonance imaging to look for the tumor. In most cases, they found a small growth, often no larger than a pea, hidden within the pituitary gland. However, in some children, the scans showed nothing at all, a common challenge in pediatric cases where the tumors are so small they are invisible to even the most advanced cameras. Despite this, the surgeons proceeded with the operation, aiming to remove the entire tumor.

The results of the initial surgery were encouraging. In thirty-one of the thirty-seven children, the disease disappeared immediately after the operation. Their hormone levels, which had been dangerously high, dropped to normal ranges. For the few children whose disease did not vanish right away, or for those who saw it return later, the team did not give up. They offered a second round of surgery, radiation therapy, or in two cases, the removal of the adrenal glands. Through these additional steps, the team eventually achieved a state of remission in thirty-six of the thirty-seven children, a success rate of nearly ninety-eight percent. This means that after all treatments were complete, only one child continued to struggle with the disease.

Beyond simply removing the tumor, the study tracked how the children's bodies healed over the years. The high blood pressure, diabetes, and obesity that had plagued them began to resolve in the vast majority of patients. Girls who had stopped menstruating due to the hormonal imbalance saw their cycles return to normal. The researchers also watched for the return of the disease, which is a known risk even after successful surgery. Over the course of their long follow-up, only three children experienced a recurrence. This translated to a very low rate of the disease coming back, suggesting that the initial treatment, when followed by careful monitoring and timely intervention if needed, provides a durable cure for most.

The study also shed light on the physical toll of the surgery itself. While the procedure is generally safe, it is not without risks. Some children experienced temporary leaks of fluid that surrounds the brain, or a temporary condition where the body lost too much water. However, these issues were manageable, and no child suffered permanent vision loss or died from the surgery. The team noted that finding the tiny tumor was often difficult, especially when the MRI scans were unclear, requiring the surgeons to explore the area carefully. This difficulty sometimes led to a higher rate of minor complications during the operation, but the long-term benefits of removing the tumor far outweighed these short-term risks.

One of the most striking findings was the disconnect between what the MRI scans showed and what the pathologists found under a microscope. In nearly half of the cases where the surgeons removed tissue, the lab tests showed no tumor at all, even though the children had been cured. This suggests that the tumors are so small and elusive that they can be missed by imaging, yet removing the surrounding tissue can still stop the disease. It also highlights that a "normal" scan does not mean a child is safe from the disease, and conversely, a normal-looking piece of tissue after surgery does not mean the surgery failed. The cure often comes from the surgeon's skill in locating and removing the source of the problem, even when the source is invisible on a scan.

The researchers concluded that for children with this rare and difficult disease, surgery performed by an experienced team offers the best chance for a full recovery. The data showed that the disease could be controlled for the long term, allowing children to grow, develop, and live without the burden of excess cortisol. However, the study also emphasized that the job is not done once the surgery is over. Because the disease can return years later, these children need lifelong check-ups to monitor their hormone levels. The success of the treatment relies not just on the operation itself, but on a continuous partnership between the patient, the family, and the medical team to catch any signs of trouble early. This approach, combining skilled surgery with vigilant, long-term care, has proven to be a powerful way to restore health to children facing this challenging condition.